Literature DB >> 28411417

Heart rate variability and cordance in rapid eye movement sleep as biomarkers of depression and treatment response.

Marcel A Pawlowski1, Mary Gazea2, Bastian Wollweber1, Martin Dresler3, Florian Holsboer1, Martin E Keck1, Axel Steiger1, Marek Adamczyk4, Thorsten Mikoteit5.   

Abstract

OBJECTIVES: The relevance of rapid eye movement (REM) sleep in affective disorders originates from its well-known abnormalities in depressed patients, who display disinhibition of REM sleep reflected by increased frequency of rapid eye movements (REM density). In this study we examined whether heart rate variability (HRV) and prefrontal theta cordance, both derived from REM sleep, could represent biomarkers of antidepressant treatment response.
METHODS: In an open-label, case-control design, thirty-three in-patients (21 females) with a depressive episode were treated with various antidepressants for four weeks. Response to treatment was defined as a ≥50% reduction of HAM-D score at the end of the fourth week. Sleep EEG was recorded after the first and the fourth week of medication. HRV was derived from 3-min artifact-free electrocardiogram segments during REM sleep. Cordance was computed for prefrontal EEG channels in the theta frequency band during tonic REM sleep.
RESULTS: HRV during REM sleep was decreased in depressed patients at week four as compared to controls (high effect size; Cohen's d > 1), and showed a negative correlation with REM density in both, healthy subjects and patients at week four. Further, the fourteen responders had significantly higher prefrontal theta cordance as compared to the nineteen non-responders after the first week of antidepressant medication; in contrast, HRV at week one did not discriminate between responders and non-responders.
CONCLUSIONS: Our data suggest that HRV in REM sleep categorizes healthy subjects and depressed patients, whereas REM sleep-derived prefrontal cordance may predict the response to antidepressant treatment in depressed patients.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cordance; Depression; Heart rate variability; REM density; REM sleep; Treatment response

Mesh:

Substances:

Year:  2017        PMID: 28411417     DOI: 10.1016/j.jpsychires.2017.03.026

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  6 in total

1.  ECG and Heart Rate Variability in Sleep-Related Breathing Disorders.

Authors:  Hua Qin; Fernando Vaquerizo-Villar; Nicolas Steenbergen; Jan F Kraemer; Thomas Penzel
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Co-ordination of brain and heart oscillations during non-rapid eye movement sleep.

Authors:  Christian Mikutta; Marion Wenke; Kai Spiegelhalder; Elisabeth Hertenstein; Jonathan G Maier; Carlotta L Schneider; Kristoffer Fehér; Julian Koenig; Andreas Altorfer; Dieter Riemann; Christoph Nissen; Bernd Feige
Journal:  J Sleep Res       Date:  2021-08-31       Impact factor: 5.296

3.  Using heart rate profiles during sleep as a biomarker of depression.

Authors:  Mysa Saad; Laura B Ray; Brad Bujaki; Amir Parvaresh; Iryna Palamarchuk; Joseph De Koninck; Alan Douglass; Elliott K Lee; Louis J Soucy; Stuart Fogel; Charles M Morin; Célyne Bastien; Zul Merali; Rébecca Robillard
Journal:  BMC Psychiatry       Date:  2019-06-07       Impact factor: 3.630

4.  Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.

Authors:  Céline K Stäuble; Markus L Lampert; Samuel Allemann; Martin Hatzinger; Kurt E Hersberger; Henriette E Meyer Zu Schwabedissen; Christian Imboden; Thorsten Mikoteit
Journal:  Trials       Date:  2021-12-14       Impact factor: 2.279

5.  Heritability of REM sleep neurophysiology in adolescence.

Authors:  Andjela Markovic; Michael Kaess; Leila Tarokh
Journal:  Transl Psychiatry       Date:  2022-09-21       Impact factor: 7.989

Review 6.  Depression and Sleep.

Authors:  Axel Steiger; Marcel Pawlowski
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.